Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...

A group of leading African researchers trying to develop effective vaccines against HIV is trying to figure out how to ...

COVID-19 took the lives of more than one million Americans and nearly 116,000 Californians, according to the Centers for Disease Control and Prevention.

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...

An effective HIV-1 vaccine must therefore elicit antibodies that can neutralize many variants of the virus. While broadly neutralizing antibodies (bnAbs) have been isolated from HIV-1 infected ...

A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people ...

The COVID-19 pandemic transformed over the past five years from a catastrophic threat that has killed over 7 million people ...

This research on a T-cell–targeting vaccines in HIV has implications for future study design to incorporate consideration of age and years on antiretroviral therapy (ART) to evaluate the level of ...

There is no disagreement that foreign aid makes a difference; more resources are needed, not less. An estimated US$22 billion ...

In the west of Kenya, near the shores of Lake Victoria, where I come from, a tuberculosis outbreak is no different from one that takes place anywhere else in ...

Amid an alarming outbreak in Texas, Florida has apparently joined the fray, according to a number of media sources.